Back to results
US 2025/0223318 A1Published application
Depsipeptides and uses thereof
AssigneeNovoBiotic Pharmaceuticals, LLC
InventorsDallas Hughes, Amy Spoering, Aaron J. Peoples, Losee Lucy Ling, Anthony Nitti, William Millett, Ashley Zullo, Kim Lewis, Slava Epstein, Alysha Desrosiers, Catherine Achorn, Kelly Demeo
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to novel depsipeptides, to methods for the preparation of the novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
Claims58
An isolated compound of Formula (I):
- or an enantiomer, diastereomer, tautomer, or pharmaceutically acceptable salt thereof, wherein:
- each stereocenter is indicated with an “*” and may be, independently, either R or S configuration;
- each R1, R2′, R3′, R4′, R5′,and R6′ is independently selected from the group consisting of hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted aryl, —NRbRb′, —CORc, —COORd, —CONReRe′ and an amino acid side chain;
- wherein each Ra, Ra′, Rb, Rb′, Rc, Rd, Re and Re′ is independently selected from the group consisting of hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl and substituted or unsubstituted aryl;
- and
- n is an integer from 1 to 5.
3 more elements
Dependencies are inferred from the claim text.